Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours

Veterinary Journal

Volumn 186, Issue 3, 2010, Pages 379-384

  Klopfleisch, R ^a   Schutze M ^a   Gruber, A D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Breast cancer; LTBP; Mammary tumour; Metastasis; Oestrogen receptor; TGF

Indexed keywords

ESTROGEN RECEPTOR ALPHA; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 3; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER STAGING; CONTROLLED STUDY; DOG; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; DOG DISEASES; DOGS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; LATENT TGF-BETA BINDING PROTEINS; MAMMARY NEOPLASMS, ANIMAL; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

CANIDAE; CANIS FAMILIARIS;

EID: 78649731477     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.09.014     Document Type: Article

References (21)

1. Alkarain A., Slingerland J. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Research 2004, 6:13-21.
2. Benson J.R. Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncology 2004, 5:229-239.
3. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
4. Etschmann B., Wilcken B., Stoevesand K., von der Schulenburg A., Sterner-Kock A. Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm. Veterinary Pathology 2006, 43:934-942.
5. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J.F., Niemi S., Comstock K.E., Ostrander E., Westmoreland S., Withrow S. The dog as a cancer model. Nature Biotechnology 2006, 24:1065-1066.
6. Klopfleisch R., Gruber A.D. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary carcinomas versus normal mammary glands. Research in Veterinary Science 2009, 87:91-96.
7. Klopfleisch, R., Schütze, M., Gruber, A.D., 2009. Loss of p27 protein expression in canine mammary carcinomas. Research in Veterinary Science, in press, doi:10.1016/j.rvsc.2009.08.007.
8. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
9. Massague J. The transforming growth factor-beta family. Annual Reviews in Cell and Developmental Biology 1990, 6:597-641.
10. Mauel S., Kruse B., Etschmann B., von der Schulenburg A.G., Schaerig M., Stovesand K., Wilcken B., Sterner-Kock A. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary carcinomas in vitro and in vivo. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2007, 115:687-700.
11. Misdorp W., Else R.W., Hellmén E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and the Cat 1999, vol. 7. Armed Forces Institute of Pathology, Washington.
12. Munson L., Moresco A. Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Disease 2007, 28:7-21.
13. Pierelli L., Marone M., Bonanno G., Mozzetti S., Rutella S., Morosetti R., Rumi C., Mancuso S., Leone G., Scambia G. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential. Blood 2000, 95:3001-3009.
14. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A. P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes and Development 1994, 8:9-22.
15. Roberts A.B. Molecular and cell biology of TGF-beta. Mineral and Electrolyte Metabolism 1998, 24:111-119.
16. Sterner-Kock A., Thorey I.S., Koli K., Wempe F., Otte J., Bangsow T., Kuhlmeier K., Kirchner T., Jin S., Keski-Oja J., von Melchner H. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes and Development 2002, 16:2264-2273.
17. Taipale J., Saharinen J., Hedman K., Keski-Oja J. Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. Journal of Histochemistry and Cytochemistry 1996, 44:875-889.
18. Toyoshima H., Hunter T. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74.
19. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Speleman, F., 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3. doi: (RESEARCH0034). doi:10.1186/gb-2002-3-7-research0034.
20. Wakefield L.M., Yang Y.A., Dukhanina O. Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models. Breast Cancer Research 2000, 2:100-106.
21. Wakefield L.M., Piek E., Bottinger E.P. TGF-beta signaling in mammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 2001, 6:67-82.